Le Lézard
Classified in: Covid-19 virus
Subject: Lawsuit

INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Fox Corporation's Directors and Officers for Breach of Fiduciary Duties ? FOX, FOXA


Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national securities and consumer rights litigation firm, is investigating whether certain directors and officers of Fox Corporation ("Fox") (NASDAQ: FOX, FOXA) breached their fiduciary duties to Fox and its shareholders. If you are a Fox shareholder, you are encouraged to contact attorney Joe Pettigrew for additional information at (844) 818-6982, or [email protected].

Scott+Scott is investigating whether members of Fox's board of directors or senior management failed to manage Fox in an acceptable manner, in breach of their fiduciary duties, and whether Fox and its shareholders have suffered damages as a result.

On February 4, 2021, Smartmatic USA Corporation ("Smartmatic") filed a defamation lawsuit against Fox, alleging that Smartmatic suffered severe harm after numerous Fox News on-air personalities made misrepresentations about Smartmatic's business in the wake of the November 2020 presidential election. Fox News personalities also made repeated misstatements about the nature and severity of the COVID-19 pandemic.

What You Can Do

If you are a Fox shareholder, you may have legal claims against Fox's directors and officers. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew toll-free at (844) 818-6982 or [email protected].

About Scott+Scott Attorneys at Law LLP

Scott+Scott has significant experience in prosecuting major securities, antitrust, and consumer rights actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Amsterdam, Connecticut, California, and Ohio.

Attorney Advertising


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: